Jones Day is a global law firm with more than 2,500 lawyers across five continents. The Firm is distinguished by a singular tradition of client service; the mutual commitment to, and the seamless collaboration of, a true partnership; formidable legal talent across multiple disciplines and jurisdictions; and shared professional values that focus on client needs.
To print this article, all you need is to be registered or login on Mondaq.com.
Since the last Jones Day Update, FDA determined that JADELLE (levonorgestrel) Implant, 75mg was not
withdrawn for reasons of safety or effectiveness. This
determination will allow FDA to approve abbreviated new drug
applications for the drug, if all other legal and regulatory
requirements are met.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
FDA Determines Levonorgestrel Drug Not Withdrawn For Reasons Of Safety Or Effectiveness
United StatesFood, Drugs, Healthcare, Life Sciences
Contributor
Jones Day is a global law firm with more than 2,500 lawyers across five continents. The Firm is distinguished by a singular tradition of client service; the mutual commitment to, and the seamless collaboration of, a true partnership; formidable legal talent across multiple disciplines and jurisdictions; and shared professional values that focus on client needs.